Collector
Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered | Collector
Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered
Forbes

Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.

Go to News Site